Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgaris
British Journal of Dermatology, 04/26/2012
Clinical Article
Behzad M et al. – The present findings show that the combination of immunoadsorption (IA) and rituximab (Rtx) induces rapid clinical remission and long–term control in difficult–to–treat pemphigus.
